During the past 20 years, artemisinin-based medicines have contributed to a decrease in malaria-related mortality. Looking ahead to the next 20, resistance to existing medicines will be one of the toughest challenges we face. Take a look at this image slideshow to learn about MMV’s multipronged approach to tackling the issue of antimalarial drug resistance.